000 01424 a2200385 4500
005 20250516045642.0
264 0 _c20120628
008 201206s 0 0 eng d
022 _a1573-4978
024 7 _a10.1007/s11033-011-1204-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZalloum, Imad
245 0 0 _aGenetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole.
_h[electronic resource]
260 _bMolecular biology reports
_cApr 2012
300 _a4195-200 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a2-Pyridinylmethylsulfinylbenzimidazoles
_xpharmacokinetics
650 0 4 _aAdult
650 0 4 _aAryl Hydrocarbon Hydroxylases
_xgenetics
650 0 4 _aCytochrome P-450 CYP2C19
650 0 4 _aDemography
650 0 4 _aGene Frequency
_xgenetics
650 0 4 _aGenetics, Population
650 0 4 _aGenotyping Techniques
650 0 4 _aHumans
650 0 4 _aJordan
650 0 4 _aLansoprazole
650 0 4 _aMale
650 0 4 _aPolymorphism, Single Nucleotide
_xgenetics
650 0 4 _aTime Factors
700 1 _aHakooz, Nancy
700 1 _aArafat, Tawfiq
773 0 _tMolecular biology reports
_gvol. 39
_gno. 4
_gp. 4195-200
856 4 0 _uhttps://doi.org/10.1007/s11033-011-1204-5
_zAvailable from publisher's website
999 _c21016767
_d21016767